Golden
eGenesis

eGenesis

A Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry.

In August 2018 eGenesis has disclosed $40m in funding by ARCH Venture Partners, Biomatics Capital Partners, Khosla Ventures, and Fan Ventures.

eGenesis' stated goal is to make xenotransplantation a routine medical procedure. The company is a Cambridge, MA-based startup that's using the gene-editing tool CRISPR to make pig organs viable for transplants into people.

The company raised $38 million in March 2017 and is cofounded by Harvard geneticist George Church and Luhan Yang. Their research is focusing on removing certain genes in pigs that could cause diseases or organ rejection in humans, making it possible for those pig organs to be transplanted. eGenesis announced in the journal Science that it had produced 37 piglets that had inactivated Porcine Endogenous Retrovirus, or PERV.

eGenesis scientists collaborated with scientists at QihanBio in Hangzhou, China on research that combined PERV knockouts with 13 other genetic changes designed to prevent immune rejection. Lead author on the research paper published in 2019 in BioRxriv is eGenesis’ Chief Scientific Officer, Luhan Yang, who is also CEO of QihanBio. Modifications were done in pig ear cells. The pig ear cells were used to generate pig clones. The nuclei of the ear cells, containing the modified DNA, were transferred into eggs from ovaries collected at a slaughterhouse. A second round of editing was used to remove PERV sequences followed by another round of cloning by transferring nuclei to eggs.

Timeline

November 2019

eGenesis raises a $100,000,000 series B round from Fresenius Medical Care, ARCH Venture Partners, Khosla Ventures, Biomatics Capital Partners, Wellington Partners, Bayer and Alta Partners.

2015

eGenesis was founded.

Funding rounds

1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Co-founder

Luhan Yang

Co-founder, CSO

Further reading

Title
Author
Link
Type
Date

Eyeing organs for human transplants, companies unveil the most extensively gene-edited pigs yet

Web

December 19, 2019

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References